Research News and Research

RSS

NHMRC awards Development Grant to speed up chronic wound treatment

A new treatment that could one day benefit burns victims, diabetes sufferers and the elderly - by fast tracking the healing of chronic wounds - has taken another step towards commercialization.

29 Jan 2010

DNA Medicine Institute awarded Phase II NASA SBIR grant for developing nanoscale diagnostic technologies

DNA Medicine Institute, a commercial organization focused on advancing human health through innovation, today announced it has been awarded a Phase II Small Business Innovation Research (SBIR) contract from the National Aeronautics and Space Administration (NASA). The contract is designed to develop nanoscale diagnostic technologies that facilitate whole health analysis in a single drop of blood.

29 Jan 2010

QIAGEN hosts panel discussion to educate public about the emerging promise of personalized medicine

The treatment of illness has traditionally been based on the law of averages – what works best for the largest number of patients. As a result, billions of dollars are spent every year on treatments that could be ineffective or even harmful for some patients. What if doctors could tell with a simple test which course of treatment would be best for a particular patient?

From QIAGEN Manchester Limited 29 Jan 2010

Decades of discrimination leaves minorities drastically underrepresented in the medical profession

Although the number of minorities in the medical profession has risen in recent years, decades of discrimination still leaves them drastically underrepresented in the field, as chronicled in new report appearing in the February issue of the journal Academic Medicine.

29 Jan 2010

New Tel Aviv University study shows early intervention could prevent mind altering disorder

The onset of schizophrenia is not easy to predict. Although it is associated with as many as 14 genes in the human genome, the prior presence of schizophrenia in the family is not enough to determine whether one will succumb to the mind-altering condition. The disease also has a significant environmental link.

29 Jan 2010

Flexion Therapeutics acquires rights to clinical-stage compounds from four pharmaceutical partners

Flexion Therapeutics today announced agreements with four major pharmaceutical partners, acquiring the rights to four clinical-stage compounds, and gaining investment from the world’s biggest pharmaceutical company.

29 Jan 2010

New research raises hopes that immune rejection of embryonic stem cell therapies can be avoided without drugs

New research in the FASEB Journal shows that bone marrow cells fuse to different types of cells, including embryonic stem cells, creating new hybrids that may evade immune rejection

29 Jan 2010

Health benefits of aerobics can be greatly affected by what you eat after exercise

Many of the health benefits of aerobic exercise are due to the most recent exercise session (rather than weeks, months and even years of exercise training), and the nature of these benefits can be greatly affected by the food we eat afterwards, according to a study published in the Journal of Applied Physiology (http://jap.physiology.org).

29 Jan 2010

APF survey reveals breakthrough cancer pain causes medical and financial hardships for cancer patients

A new survey released today by the American Pain Foundation (APF) reveals that breakthrough cancer pain — sudden, temporary flares of severe pain that occur even when pain medication is used — is one of the most challenging aspects of having cancer, according to three out of four (75 percent) U.S. adults who have ever been diagnosed with cancer and experience this type of pain.

29 Jan 2010

OMT, a viable option for treating back pain in the third trimester of pregnancy

For many pregnant women, it's inevitable. As their pregnancy progresses, tasks that involve the low back often get more difficult. It is harder to bend over, lift, sit or walk for long periods of time, and back pain increases. Treating back pain, and improving daily function relative to tasks that involve the low back is a challenge because pregnant women are limited to treatments that will not create problems for their developing baby.

29 Jan 2010

CAMH signs licensing agreement to develop and market genetic test for degenerative muscle disorder

The Centre for Addiction and Mental Health (CAMH) has signed a licensing agreement with a Massachusetts firm to develop and market an innovative genetic test for a recently identified degenerative muscle disorder. The disorder tends to strike adults in their early 30s.

From Thermo Fisher Scientific Inc. 29 Jan 2010

AHRQ and American College Of Cardiology team up to study risks and benefits of ICDs

A $3.5 million research project that will study the long-term benefits and risks of implantable cardioverter defibrillators (ICDs) in patients at risk of death from ventricular fibrillation will be supported by HHS' Agency for Healthcare Research and Quality and the American College of Cardiology, the two groups announced today.

29 Jan 2010

Submissions invited for 2010 SOGC/CFWH Journalism Awards for Excellence in Women's Health Reporting

The Society of Obstetricians and Gynaecologists of Canada (SOGC), in collaboration with the Canadian Foundation for Women's Health (CFWH), is calling for submissions for the 2010 SOGC/CFWH Journalism Awards for Excellence in Women's Health Reporting.

29 Jan 2010

Nontoxic drug halts and reverses rheumatoid arthritis

A researcher from Northwestern University Feinberg School of Medicine has invented a novel way to halt and even reverse rheumatoid arthritis. He developed an imitation of a suicide molecule that floats undetected into overactive immune cells responsible for the disease.

29 Jan 2010

Tufts CSDD announces the launch of new website

The Tufts Center for the Study of Drug Development, the world's leading, independent authority on the nature and pace of pharmaceutical and biotech drug development, today announced the launch of its new website that makes it easier for industry professionals and others to research critical drug development issues.

29 Jan 2010

Labeling update for Tibotec Therapeutics' PREZISTA tablets approved

Tibotec Therapeutics announced today that the U.S. Food and Drug Administration (FDA) has approved a labeling update for PREZISTA® (darunavir) tablets to include 96-week data from the ARTEMIS and TITAN studies.

29 Jan 2010

VisEn Medical acquires Bayer Schering Pharma AG's fluorescence agent intellectual property portfolios

VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today that it has acquired the fluorescence imaging agent intellectual property portfolios and related technology platforms from Bayer Schering Pharma AG, Germany.

29 Jan 2010

Researchers reveal major shifts in structure of scientific research

How has the structure of scientific research changed over the past decade? A team of researchers from Ume- University, Sweden, and the University of Washington, USA, aims to answer this question and others in a study published on January 27th in the online, open-access journal PLoS ONE.

29 Jan 2010

Study shows doctors cut back their workload for fear of malpractice lawsuits

A new study shows that the number of hours physicians spend on the job each week is influenced by the fear of malpractice lawsuits.

29 Jan 2010

iPierian receives UK patent for induced pluripotent stem cell technology

iPierian, Inc., a biopharmaceutical company focused on changing the paradigm of drug discovery and development through the application of cellular reprogramming, today announced that the Intellectual Property Office in the United Kingdom has issued a Notification of Grant to iPierian for UK patent No. GB2450603, its first patent related to induced pluripotent stem cell (iPSC) technology.

29 Jan 2010

Research News and Research

NHMRC awards Development Grant to speed up chronic wound treatment

DNA Medicine Institute awarded Phase II NASA SBIR grant for developing nanoscale diagnostic technologies

QIAGEN hosts panel discussion to educate public about the emerging promise of personalized medicine

Decades of discrimination leaves minorities drastically underrepresented in the medical profession

New Tel Aviv University study shows early intervention could prevent mind altering disorder

Flexion Therapeutics acquires rights to clinical-stage compounds from four pharmaceutical partners

New research raises hopes that immune rejection of embryonic stem cell therapies can be avoided without drugs

Health benefits of aerobics can be greatly affected by what you eat after exercise

APF survey reveals breakthrough cancer pain causes medical and financial hardships for cancer patients

OMT, a viable option for treating back pain in the third trimester of pregnancy

CAMH signs licensing agreement to develop and market genetic test for degenerative muscle disorder

AHRQ and American College Of Cardiology team up to study risks and benefits of ICDs

Submissions invited for 2010 SOGC/CFWH Journalism Awards for Excellence in Women's Health Reporting

Nontoxic drug halts and reverses rheumatoid arthritis

Tufts CSDD announces the launch of new website

Labeling update for Tibotec Therapeutics' PREZISTA tablets approved

VisEn Medical acquires Bayer Schering Pharma AG's fluorescence agent intellectual property portfolios

Researchers reveal major shifts in structure of scientific research

Study shows doctors cut back their workload for fear of malpractice lawsuits

iPierian receives UK patent for induced pluripotent stem cell technology

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News